Filter by
 

Publication date

Main subject

Main subject

Keywords

Keywords

Press and media

Register here to receive our news releases

Subscribe

Register here to receive our newsletter

Subscribe

Media support

To schedule interviews, obtain informed comment, request written contributions or receive the latest news on the agency, please contact our media relations sector:

Kathy Robertson
Principal manager
Media relations and corporate communication

 Email: Kathy Robertson

 Tel: (351) 211 21 02 00/32

 Mobile. (351) 935 994 027

News

Displaying 1 - 20 of 775

Wastewater samples from over 100 European cities reveal latest drug-taking trends

22.03.2023

The latest findings from the largest European project in the science of wastewater analysis are released today in Wastewater analysis and drugs — a European multi-city study, published by the Europe-wide

EMCDDA Director pays official visit to Austria

20.03.2023

(20.03.2023) EMCDDA Director Alexis Goosdeel starts an official three-day visit to Austria today where he will meet with high-level officials including the Minister of Health, Johannes Rauch, and Minister of Justice, Dr Alma Zadić.

EMCDDA at annual UN Commission on Narcotic Drugs

13.03.2023

An EMCDDA delegation is attending the sixty-sixth session of the Commission on Narcotic Drugs (CND) in Vienna this week (13-17 March), where it is providing technical support to the European Commi

Women and drugs — need to scale up gender-sensitive services in Europe

08.03.2023

Women make up approximately a quarter of all people with serious drug problems in Europe and around one-fifth of all entrants to drug treatment. Yet much still needs to be done to provide interventions tailored to their needs, with many drug services remaining male-oriented.

EMCDDA announces changes to its Scientific Committee line-up

03.03.2023

The EMCDDA Scientific Committee, meeting in Lisbon this week, re-elected its Chair and Vice Chair and welcomed four new members. Chair Prof. Dr.

IPA8 bursaries for 2023 European Drugs Summer School

27.02.2023

Bursaries for the 2023 European Drugs Summer School (EDSS) are currently being offered through the EMCDDA’s Instrument for Pre-accession Assistance 8 (IPA8) project.

EU4MD II bursaries for 2023 European Drugs Summer School

24.02.2023

Two bursaries for the 2023 European Drugs Summer School (EDSS) are currently being offered through EMCDDA’s EU4Monitoring Drugs II (

New EMCDDA work programme prepares agency for significant changes ahead

24.02.2023

Message from the Director 1/2023

Bursaries for students and professionals from Latin American and Caribbean countries for the 2023 European Drugs Summer School

20.02.2023

Two bursaries covering the registration fee for the 2023 European Drugs Summer School (EDSS) are currently being offered through the EMCDDA’s partnership with the COPOLAD III programme.

Europe and Central Asia cooperate to train experts in collecting and analysing drug use data

15.02.2023

A working arrangement was signed this morning in Madrid between FIIAPP/Spanish Cooperation and the EMCDDA in order to train and update the knowledge an

Founding regulation of the EMCDDA adopted on this day, 30 years ago

08.02.2023

(08.02.2023) On this day, 30 years ago, the adoption of Council Regulation (EEC) No 302/93 heralded the

Port of Antwerp welcomes officials following continued rise in cocaine seizures

07.02.2023

(07.02.2023) European Commissioner for Home Affairs Ylva Johansson is visiting the Port of Antwerp today, following the continued rise in the quantity of cocaine seized at the port.

EMCDDA intensifies its cooperation with the Western Balkans and the European Neighbourhood Policy area

31.01.2023

This month, the EMCDDA has launched two new projects which will intensify its cooperation with the Western Balkans and the European Neighbourhood Policy area (ENP).

New phase of collaboration between the EMCDDA and the Ukrainian Ministry of Health

30.01.2023

This month sees the start of a new phase of collaboration between the EMCDDA and Ukraine following the signing of a Working Arrangement between the agency and the Ukrainian Ministry of Health.

Bursaries for students from Latin American and Caribbean countries for the 2023 European Drugs Winter School

23.01.2023

Professionals, academics or experts from Latin American and Caribbean countries (LAC) (1) will have an opportunity to participate in the European Drugs Winter School (EDWS) this year, thanks to two bursaries covering the

Sweden takes over the EU presidency with a promise to be ‘greener, safer and freer’

13.01.2023

This month, Sweden took over the rotating presidency of the Council of the EU with a pledge to focus on security, competitiveness, green and energy transitions, democratic values and the rule of law.

Czech EU Presidency: a human rights-based approach to drug policy

19.12.2022

This month, the Czech six-month Presidency of the Council of the EU draws to a close.

EMCDDA technical expert meeting on hexahydrocannabinol (HHC) and related cannabinoids

19.12.2022

On 16 December, the EMCDDA held the first ‘Technical expert meeting on hexahydrocannabinol (HHC) and related semi-synthetic cannabinoids (SSCs)’ as part of its ongoing work to support EU and national preparedness and response to emerging NPS risks. Hexahydrocannabinol is the first semi-synthetic

Season’s greetings and warm wishes for a peaceful 2023

19.12.2022

As we reach the end of 2022, we look back on a year which has seen Europe face the trials of war, growing instability in food and energy supplies and ongoing social and economic challenges as we emerge from the COVID-19 pandemic.

Service awards for four long-standing members of the EMCDDA Management Board

16.12.2022

Four long-standing members of the EMCDDA Management Board received awards this week in recognition of their extraordinary dedication and service to the agency. The recipients were: 
Loading